Cardinal Health (NYSE:CAH - Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided EPS guidance of 8.150-8.200 for the period, compared to the consensus EPS estimate of 8.130. The company issued revenue guidance of -.
Analyst Ratings Changes
Several research firms have recently weighed in on CAH. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Wells Fargo & Company raised Cardinal Health from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Evercore ISI reissued an "outperform" rating and issued a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Morgan Stanley set a $181.00 price objective on Cardinal Health and gave the stock an "overweight" rating in a research report on Friday, June 13th. Finally, Bank of America lifted their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $157.43.
Check Out Our Latest Stock Analysis on Cardinal Health
Cardinal Health Stock Up 0.3%
CAH stock traded up $0.55 during mid-day trading on Monday, reaching $163.95. 2,564,525 shares of the company traded hands, compared to its average volume of 2,230,985. The stock has a market cap of $39.13 billion, a price-to-earnings ratio of 25.58, a P/E/G ratio of 1.82 and a beta of 0.66. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $166.32. The firm's 50 day moving average price is $150.11 and its 200 day moving average price is $134.48.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.08 EPS. On average, analysts anticipate that Cardinal Health will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.25%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's payout ratio is 31.51%.
Hedge Funds Weigh In On Cardinal Health
A hedge fund recently raised its stake in Cardinal Health stock. Jones Financial Companies Lllp lifted its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 198.3% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,112 shares of the company's stock after buying an additional 14,034 shares during the period. Jones Financial Companies Lllp's holdings in Cardinal Health were worth $27,000 at the end of the most recent reporting period. 87.17% of the stock is owned by institutional investors.
About Cardinal Health
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
